Seminar: Sjoerd Elias

Onderzoek met kleine aantallen: hoe krijg je grootse resultaten…

15 June 2017 15:00 hrs. - 16:00 hrs.
Tuinzaal, route 706
Onderzoek met kleine aantallen: hoe krijg je grootse resultaten…

Sjoerd Elias, Ass. Professor of Clinical Epidemiology, Juius Center for Health Sciences and Primary Care, UMC Utrecht


Carla van Herpen, Dept. of Medical Oncology, Radboudumc

15-06-2017 15:00:0015-06-2017 16:00:00Europe/AmsterdamOnderzoek met kleine aantallen: hoe krijg je grootse resultaten… Tuinzaal, route

Remarks / more information:

undefinedSince 2008, Sjoerd Elias is appointed Assistant Professor of Clinical Epidemiology at the Julius Center for Health Sciences and Primary Care (University Medical Center Utrecht), and he participates in the Julius Center research programs Cancer and Methodology. He obtained his MSc in Clinical Epidemiology (2002) at the Netherlands Institute for Health Sciences, and his PhD at Utrecht University. He finished Medical School in 2005 and has clinical experience as a resident in radiology (Gelre Ziekenhuizen Apeldoorn, the Netherlands). A personal Dutch Cancer Society Research Fellowship (2009-2013) allowed him to conduct research at the Molecular Imaging Program at Stanford (professor SS Gambhir), the Department of Radiology and Biomedical Imaging at the University of California San Francisco and the Department of Molecular Pathology at the Netherlands Cancer Institute. He is a member of the Medical Ethical Review Board at the UMC Utrecht, teaches Clinical Epidemiology (also internationally) and is coordinator of two science courses in the Selective Utrecht Medical Master (SUMMA) program.

Interests and Focus

Following research on the relation between energy balance (caloric restriction/physical activity) and cancer risk, he now focuses on the clinical evaluation and translation of biomarkers, particularly for cancer classification (i.e. diagnostic, prognostic, and predictive markers). These markers include emerging imaging technologies (e.g. molecular imaging), omics-based tests, and organoids. He has both experience in preclinical research as well as applied clinical science, and has expertise in the design and analysis of studies spanning all (translational) phases of biomarker development. He participates in several (multicenter) clinical projects, for instance to evaluate emerging molecular imaging techniques for cancer (e.g. CTMM-MAMMOTH and AD6-IMPACT), to improve the diagnostic work-up of primary care patients with abdominal complaints (ZonMW-CEDAR), to deliver proof-of-concept of targeted treatment for mesenchymal colorectal cancer (KWF/ZonMW-ImPACCT), and to curb overtreatment of elderly breast cancer patients (KWF-TOP1).


<< back to all events